Items 71 ~ 80 of 5370, Page 8 of 537 
  06/11/2019 MERCK - Business
FDA Approves Two New Indications for Merck’s KEYTRUDA® (pembrolizumab)
- KEYTRUDA Now Approved for First-Line Treatment of Patients with Metastatic or with Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma as Monotherapy for Patients Whose Tumors Express PD-L1 (CPS ≥1) or in Combination with Platinum and Fluorouracil (FU) Regardless of PD-L1 Expression
  06/10/2019 American College of Occupational and Environmental Medicine (ACOEM) - Health and Science
Mental and Physical Health Drive Employee Productivity
- Mental and physical health are the most important factors affecting workplace productivity, reports an open-access paper in the June Journal of Occupational and Environmental Medicine.
  06/10/2019 Medtronic - Business
Real-World Data from Guardian(TM) Connect and Sugar.IQ(TM) Reveal Improved Diabetes Outcomes
- ugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance
  06/10/2019 Medtronic - Business
Medtronic Announces Its Forthcoming Robotic Assisted Surgical Platform to Feature Three-Dimensional Vision System from KARL STORZ
- Four Year Partnership Made Public Today
  06/10/2019 MERCK - Business
Merck to Acquire Tilos Therapeutics
- Merck Gains Portfolio of Investigational Antibodies Modulating TGFβ
  05/16/2019 WHO - Public Health
Too many babies are born too small
- Around one in seven of all babies worldwide are born with a low birthweight
  05/16/2019 American Academy of Ophthalmology - Public Health
Do These Seven Things Today, to Save Your Sight Tomorrow
- The American Academy of Ophthalmology urges young adults to protect their eyes to prevent vision loss in the future
  05/16/2019 MERCK - Business
Merck to Present New Analyses for JANUVIA® (sitagliptin) and STEGLATRO™ (ertugliflozin), and Real-World Data Studies at the 79th Scientific Sessions of the American Diabetes Association
- Real-World Evidence Research to Explore Socioeconomic, Racial and Ethnic Disparities in Diabetes Treatment
  05/16/2019 Abbott - Business
New ZonePerfect® Keto is 100% #TrueKeto with the Proven Blend of Macros for Effective Results
- Abbott's ZonePerfect Keto shakes and powders are formulated with a science-based macronutrient ("macros") ratio of 75% fat, 20% protein and 5% carbohydrates to support ketosis and burn body fat / ZonePerfect Keto helps fulfill a keto lifestyle on the go - offering the only true keto ready-to-drink option available nationwide at major retailers
  05/15/2019 MERCK - Business
New Research from Merck’s Broad Oncology Clinical Development Program to be Presented at 2019 ASCO Annual Meeting
- First-Time Data from POLO Trial Evaluating LYNPARZA ® (olaparib) in Germline BRCA-Mutated Metastatic Pancreatic Cancer in Plenary Session and ASCO Press Program / KEYTRUDA ® (pembrolizumab) Five-Year Survival Data in Advanced Non-Small Cell Lung Cancer (NSCLC) from KEYNOTE-001 Trial in ASCO Press Program / Overall Survival Data for KEYTRUDA in Metastatic Renal Cell Carcinoma (RCC), Recurrent/Metastatic Head and Neck Cancer and Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer

<<  <  [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8[9]  [10]  >  >>